Periodontal regeneration with Geistlich Fibro-Gide^®

"The pandemic has fueled e-learning."

Thomas Pfyffer | Switzerland

Five questions for Dr. Friedrich Buck, who is responsible for Geistlich's "Scientific Education" with his team. He himself is a dentist with many years of experience. What current topics are driving him and what dental education offers should you be aware of following the pandemic?

“Why should we settle for 40-year old implant success criteria?”

Dr. Marjan Gilani | Switzerland

Is a couple of millimeters of bone remodeling around implants normal? Is this implant successful? Prof. Tomas Linkevičius believes that with the advance of science and biomaterials it is not too ambitious to expect no bone loss after implant placement.¹

“Everything may work in the short term – but not necessarily in the long-term.”

Dr. Marjan Gilani | Switzerland

What makes a biomaterial “premium”? We discussed with Dr. Mario Roccuzzo, Italy, about design, manufacturing standards, long-term outcomes and his journey of using biomaterials in the last 30 years.

When orthodontic treatment causes perio problems

Dr. Scott H. Froum | United States

There are many advantages that can come with saving natural teeth. The good news is that, in the era of advanced biomaterials and surgical techniques, it is sometimes possible to save hopeless teeth. What does it take to save teeth that have been diagnosed as beyond repair?

“Time to Unleash Geistlich’s Energy!"

Thomas Pfyffer | Switzerland

Having started at Geistlich from the beginning of 2021, Dr Ralf Halbach took the helm as CEO from July. We review his first few months in the company and hazard a guess at what might be expected for Geistlich in the future.

“We want to carry the message of regeneration"

Thomas Pfyffer | Switzerland

Paul Note has been at the helm of Geistlich Pharma for 16 years. On the occasion of the handover to the new CEO Ralf P. Halbach in mid-2021, we look back with him on the eventful and expansive time at Geistlich.

Saving teeth affected by large periapical defects

Prof. Jose Mauricio Paradella de Camargo | Brazil

Instead of extracting or replacing teeth with dental implants, endodontists prefer to prolong the functionality of teeth with traumatized roots. Today advances in technology, procedures and biomaterials allow endodontists to save teeth at an outstanding rate of success.

What do implant dentistry and riding a vespa have in common?

Dr. Alfonso Rao | United Kingdom

 

 

Hope for the hopeless!

Dr. Pierpaolo Cortellini | Italy

Over the past 20-years Dr. Pierpaolo Cortellini has shown that a “hopeless tooth” is anything but hopeless. We discussed long-term outcomes, cost-efficiency and reasonable beliefs and expectations.

Discover “The New Daily Practice”

Verena Vermeulen | Switzerland

Geistlich Biomaterials' "The New Daily Practice" website is live!

Orthodontic tooth movement makes new bone formation

Dr. Pal Nagy | Hungary

The observation of multinucleated giant cells and cutting cones confirms the safety and predictability of periodontal bony regeneration combined with OTM using Geistlich Bio-Oss^®.

Palate free innovation into practice

Prof. Paulo Fernando Mesquita de Carvalho | Brazil

A stable and healthy peri-implant soft-tissue is the foundation of implant success and aesthetic excellence.

Geistlich Mucograft^®: better Comfort, Cosmetics and Convenience

Dr. Michael K. McGuire | United States

In a Randomized Controlled Clinical Trial, Dr. McGuire et al. have compared the long-term outcomes of recession coverage with Geistlich Mucograft^® and free gingival graft.¹ Results were equivalent and stable in both test groups, with less morbidity and higher patient satisfaction with Geistlich Mucograft^®. We asked Dr. McGuire to answer some key questions about his findings.